Holen Sie sich die Stockscreener-App
2.66
0.75%
-0.02
Vorhandelsmarkt:
2.66
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Ng George K - Moomoo
Insider Buying: Russell Skibsted Acquires Additional Shares of P - GuruFocus
Processa Pharmaceuticals CFO Skibsted buys $5,891 in stock By Investing.com - Investing.com Australia
Processa Pharmaceuticals CFO Skibsted buys $5,891 in stock - Investing.com
Processa Pharma strategy chief Lin buys $4,064 in stock By Investing.com - Investing.com India
Processa Pharma strategy chief Lin buys $4,064 in stock - Investing.com
Processa (PCSA) CAO Wendy Guy buys 1,748 shares in open-market trade - Stock Titan
Processa Pharmaceuticals president David Young buys $4,589 in shares By Investing.com - Investing.com Australia
Processa Pharmaceuticals CEO George Ng buys $5,471 in company stock By Investing.com - Investing.com India
Processa Pharmaceuticals president David Young buys $4,589 in shares - Investing.com
Processa Pharmaceuticals CEO George Ng buys $5,471 in company stock - Investing.com
David Young of Processa (NASDAQ: PCSA) buys 1,706 shares at $2.69 - Stock Titan
Processa Pharmaceuticals (PCSA) CFO adds 2,190 shares in open-market buy - Stock Titan
Processa (NASDAQ: PCSA) CEO George Ng buys 2,034 shares in open-market trade - Stock Titan
Processa (PCSA) strategy chief buys 1,511 shares at $2.69 - Stock Titan
Processa (NASDAQ: PCSA) CDO adds 1,986 shares in open-market buy - Stock Titan
2025 Executive Compensation, Ownership, and Governance Overview for Heatwurx, Inc. (Now Based in Vero Beach, FL) - Minichart
Processa Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Ng George Kmoomoo - Moomoo
Processa Pharmaceuticals Announces Transition of Chief Development Officer - TipRanks
Processa Pharmaceuticals CEO George Ng buys $5,414 in stock By Investing.com - Investing.com Canada
Processa Pharmaceuticals (NASDAQ: PCSA) details governance, pay and ownership in 10-K/A - Stock Titan
Chief development leader at Processa (NASDAQ: PCSA) moves to part-time post - Stock Titan
Processa Pharmaceuticals CEO George Ng buys $5,414 in stock - Investing.com
Processa (NASDAQ: PCSA) CEO adds 1,843 shares in open-market buy - Stock Titan
Processa Pharmaceuticals (PCSA) CEO buys 2,136 shares in open market - Stock Titan
PCSA stock rallies 10% after hours—here’s why - MSN
Processa Pharmaceuticals Inc. (PCSA) Share Price Today | Processa Pharmaceuticals (PCSA) Live NSE/BSE - Value Research
PCSA Stock Price, Quote & Chart | PROCESSA PHARMACEUTICALS INC (NASDAQ:PCSA) - ChartMill
Is Processa Pharmaceuticals (PCSA) stock testing important levels (Pressure Mounts) 2026-04-20Wall Street Picks - Xã Thanh Hà
Processa Pharma director Young buys shares worth $4,588 By Investing.com - Investing.com Australia
Lin Patrick, Processa Pharma chief, buys $4,065 in PCSA stock By Investing.com - Investing.com South Africa
Processa Pharma director Young buys shares worth $4,588 - Investing.com
Lin Patrick, Processa Pharma chief, buys $4,065 in PCSA stock - Investing.com
Bigora Sian, chief development officer, buys Processa shares By Investing.com - Investing.com Australia
Processa Pharma CFO Skibsted buys $5892 in PCSA stock By Investing.com - Investing.com Canada
Bigora Sian, chief development officer, buys Processa shares - Investing.com
Processa Pharmaceuticals (NASDAQ: PCSA) R&D chief buys 1,545 shares in open market - Stock Titan
Processa Pharmaceuticals (PCSA) CEO adds 1,843 shares in open-market buy - Stock Titan
Processa (PCSA) strategy chief buys 1,369 shares at $2.97 - Stock Titan
Processa (NASDAQ: PCSA) CAO Wendy Guy buys 1,583 shares in open market - Stock Titan
Processa (PCSA) CDO buys 1,799 company shares in open market - Stock Titan
Processa (NASDAQ: PCSA) CFO adds 1,984 shares in open-market buy - Stock Titan
Institution Moves: Is Processa Pharmaceuticals Inc impacted by rising rates2026 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn
Market Recap: What are the risks of holding Processa Pharmaceuticals IncMarket Activity Recap & Safe Investment Capital Preservation Plans - baoquankhu1.vn
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):